Clinical trials
Phase 3 trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,043 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 22 |
| 2002 | 30 |
| 2003 | 56 |
| 2004 | 52 |
| 2005 | 72 |
| 2006 | 95 |
| 2007 | 110 |
| 2008 | 121 |
| 2009 | 92 |
| 2010 | 128 |
| 2011 | 167 |
| 2012 | 137 |
| 2013 | 125 |
| 2014 | 162 |
| 2015 | 168 |
| 2016 | 121 |
| 2017 | 157 |
| 2018 | 159 |
| 2019 | 152 |
| 2020 | 134 |
| 2021 | 156 |
| 2022 | 130 |
| 2023 | 137 |
| 2024 | 124 |
| 2025 | 133 |
| 2026 | 68 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,994 |
| Terminated | 378 |
| Active, not recruiting | 358 |
| Recruiting | 256 |
| Unknown status | 22 |
| Enrolling by invitation | 13 |
| Withdrawn | 13 |
| Not yet recruiting | 7 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 208 |
| Novartis Pharmaceuticals | 200 |
| Hoffmann-La Roche | 158 |
| Sanofi | 136 |
| Pfizer | 108 |
| Eli Lilly and Company | 104 |
| Amgen | 94 |
| Janssen Research & Development, LLC | 87 |
| Boehringer Ingelheim | 82 |
| GlaxoSmithKline | 72 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 175 |
| Carcinoma, Non-Small-Cell Lung | 138 |
| Breast Neoplasms | 128 |
| Pulmonary Disease, Chronic Obstructive | 83 |
| Arthritis, Rheumatoid | 77 |
| Diabetes Mellitus | 77 |
| Asthma | 74 |
| Neoplasms | 66 |
| Neoplasm Metastasis | 65 |
| Colitis, Ulcerative | 64 |
Trials
Showing 1 to 25 of 3,043. Each trial links to its page on Pharma Observatory.
2,943 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.